Custom Health Partners with Berenson to Go Public


Custom Health and Berenson announce plan to trade on the NYSE

Custom Health Inc. and Berenson Acquisition Corp. I (NYSE American: BACA) today announced their definitive Business Combination Agreement that is expected to result in Custom Health becoming a publicly-listed company. The transaction implies a USD $185 million pre-money equity value for Custom Health. Proceeds from the transaction and related financing are expected to be used to fuel organic growth and allow Custom Health to continue to execute on its proven add-on acquisition strategy.

Read more about this transformative partnership: Custom Health Inc. To Go Public Through Business Combination with Berenson Acquisition Corp. I (

We believe that Custom Health will be a first-of-its-kind public company within the healthcare sector, utilizing a vertically-integrated business model that leverages proprietary technology at its owned and network pharmacies to manage the full cycle of a patient’s medication and care journey.

Amir Hegazy, CFO BACA

We are very excited to work closely with the BACA team to transform the care experience for people at home. We believe that their deep mergers and acquisitions expertise coupled with our shared commitment to impact patient lives will accelerate our path to market. Guessing with medication must stop. We have the expertise, technology and comprehensive data to help people who take medication achieve the best possible health outcome.

Shane Bishop, CEO Custom Health